VAS2870 is a pan-NADPH oxidase inhibitor

Cellular and Molecular Life Sciences

Volumn 69, Issue 18, 2012, Pages 3159-3160

  Wingler, Kirstin ^a   Altenhoefer, Sebastian A ^a   Kleikers, Pamela W M ^a   Radermacher, Kim A ^a   Kleinschnitz, Christoph ^b   Schmidt, Harald H H W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOREDUCTASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; UNCLASSIFIED DRUG; VAS 2870;

BRAIN ISCHEMIA; CONFLICT OF INTEREST; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; LETTER; NONHUMAN;

ANIMALS; HUMANS; NADPH OXIDASE; STROKE;

EID: 84865651417     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1107-1     Document Type: Letter

References (7)

1. Kahles T, Brandes RP (2012) NADPH oxidases as therapeutic targets in ischemic stroke. Cell Mol Life Sci. doi:10.1007/s00018-012-1011-8
2. Wingler K, Hermans JJR, Schiffers P, Moens AL, Paul M, Schmidt HH (2011) NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol 164:866-883. doi:10.1111/j.1476-5381.2011.01249.x
3. ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M, Bekhite MM, Wartenberg M, Sauer H, Rosenkranz S (2006) Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 71:331-341. doi:10.1016/j.cardiores.2006.01.022
4. Stielow C, Catar RA, Muller G, Wingler K, Scheurer P, Schmidt HH, Morawietz H (2006) Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem Biophys Res Commun 344:200-205. doi:10.1016/ j.bbrc.2006.03.114
5. Altenhöfer S, Kleikers P, Radermacher K, Scheurer P, Rob Hermans J, Schiffers P, Ho H, Wingler K, Schmidt H (2012) The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci. doi:10.1007/s00018-012-1010-9
6. Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, Barthel K, Schuhmann MK, Herrmann AM, Meuth SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H, Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N, Schmidt HH (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 8:e1000479. doi:10.1371/journal.pbio.1000479
7. Wind S, Beuerlein K, Eucker T, Muller H, Scheurer P, Armitage ME, Ho H, Schmidt HH, Wingler K (2010) Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol 161:885-898. doi:10.1111/j.1476-5381. 2010. 00920.x